ArcDia
Turku, FI · 2 known investors
ArcDia International develops and manufactures in vitro diagnostic solutions for acute infections such as COVID-19, influenza, RSV, and CDI, enabling rapid decentralized testing in hospitals, healthcare centers, and workplaces. The company also offers mariAST for antimicrobial susceptibility testing and mariCloud for real-time epidemiological surveillance.
Investors · 2
In the news
- ArcDia - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Finland's ArcDia grabs $3.5M to fuel diagnostic test use | Fierce Biotechfiercebiotech.com · 2012
- ArcDia Raises € 2.7 million to Expand Multianalyte Point-of-Care Respiratory Tract Diagnostic Test - BioSpacebiospace.com · 2012